Table 1 Weighted baseline characteristics of study population
From: Predictive role of the dietary inflammatory index on stroke risk among hypertensive patients
Characteristics | Overall (n = 23,712) | Non-stroke (n = 21,842) | Stroke (n = 1870) | P value |
---|---|---|---|---|
Age, years | 57.16 ± 0.21 | 56.55 ± 0.21 | 66.35 ± 0.44 | < 0.0001 |
Sex, n (%) | < 0.001 | |||
Female | 12,068 (50.82) | 11,118 (50.47) | 950 (55.97) | |
Male | 11,644 (49.18) | 10,724 (49.53) | 920 (44.03) | |
Race, n (%) | < 0.001 | |||
Mexican American | 3129 (5.51) | 2949 (5.58) | 180 (4.48) | |
Non-Hispanic Black | 6354 (13.77) | 5794 (13.53) | 560 (17.35) | |
Non-Hispanic White | 10,632 (69.78) | 9744 (69.91) | 888 (67.84) | |
Other Race | 3597 (10.94) | 3355 (10.98) | 242 (10.33) | |
Education level, n (%) | < 0.0001 | |||
High school or above | 16,873 (80.79) | 15,654 (81.31) | 1219 (72.94) | |
Less than High School | 6839 (19.21) | 6188 (18.69) | 651 (27.06) | |
Marital status, n (%) | < 0.0001 | |||
Married | 10,677 (50.89) | 9950 (51.38) | 727 (43.61) | |
Other | 13,035 (49.11) | 11,892 (48.62) | 1143 (56.39) | |
Smoking, n (%) | < 0.001 | |||
Never | 11,881 (49.41) | 11,116 (49.85) | 765 (42.90) | |
Former | 7432 (31.62) | 6727 (31.40) | 705 (34.99) | |
Now | 4399 (18.96) | 3999 (18.75) | 400 (22.11) | |
Alcohol use, n (%) | < 0.0001 | |||
Never | 3715 (12.74) | 3384 (12.36) | 331 (18.42) | |
Former | 4923 (18.26) | 4360 (17.62) | 563 (27.78) | |
Mild | 8417 (37.54) | 7834 (37.84) | 583 (33.02) | |
Moderate | 3057 (14.64) | 2867 (14.93) | 190 (10.33) | |
Heavy | 3600 (16.82) | 3397 (17.25) | 203 (10.45) | |
PIR | 2.93 ± 0.03 | 2.97 ± 0.03 | 2.29 ± 0.06 | < 0.0001 |
BMI, kg/m2 | 30.85 ± 0.08 | 30.88 ± 0.08 | 30.49 ± 0.23 | 0.11 |
eGFR, mL/min/1.73m2 | 84.27 ± 0.29 | 85.24 ± 0.29 | 69.86 ± 0.75 | < 0.0001 |
FPG, mg/dL | 115.31 ± 0.35 | 114.77 ± 0.35 | 123.37 ± 1.73 | < 0.0001 |
ALT, U/L | 26.28 ± 0.21 | 26.57 ± 0.23 | 22.02 ± 0.36 | < 0.0001 |
AST, U/L | 25.97 ± 0.14 | 26.11 ± 0.15 | 23.94 ± 0.30 | < 0.0001 |
SCR, mg/dL | 0.95 ± 0.00 | 0.94 ± 0.00 | 1.11 ± 0.02 | < 0.0001 |
TG, mg/dL | 203.50 ± 1.89 | 204.44 ± 1.96 | 189.43 ± 5.81 | 0.01 |
TC, mg/dL | 199.13 ± 0.49 | 199.89 ± 0.50 | 187.82 ± 1.66 | < 0.0001 |
HDL-C, mg/dL | 52.29 ± 0.18 | 52.40 ± 0.18 | 50.70 ± 0.55 | 0.002 |
LDL-C, mg/dL | 106.59 ± 0.39 | 107.05 ± 0.40 | 99.67 ± 1.36 | < 0.0001 |
DII | 1.51 ± 0.02 | 1.48 ± 0.02 | 1.97 ± 0.06 | < 0.0001 |
DM, n (%) | < 0.0001 | |||
No | 16,584 (75.21) | 15,517 (76.35) | 1067 (58.25) | |
Yes | 7128 (24.79) | 6325 (23.65) | 803 (41.75) | |
CHD, n (%) | < 0.0001 | |||
No | 21,818 (92.52) | 20,302 (93.47) | 1516 (78.43) | |
Yes | 1894 (7.48) | 1540 (6.53) | 354 (21.57) | |
Antihypertensive drugs, n (%) | < 0.0001 | |||
No | 8244 (38.01) | 7949 (39.53) | 295 (15.52) | |
Yes | 15,468 (61.99) | 13,893 (60.47) | 1575 (84.48) | |
Hypoglycemic agents, n (%) | < 0.0001 | |||
No | 18,963 (83.81) | 17,660 (84.69) | 1303 (70.72) | |
Yes | 4749 (16.19) | 4182 (15.31) | 567 (29.28) | |
Lipid lowering drugs, n (%) | < 0.0001 | |||
No | 15,874 (68.03) | 15,024 (69.70) | 850 (43.15) | |
Yes | 7838 (31.97) | 6818 (30.30) | 1020 (56.85) | |
Antiplatelet drugs, n (%) | < 0.0001 | |||
No | 22,292 (95.15) | 20,869 (96.47) | 1221 (65.29) | |
Yes | 1420 (4.85) | 973 (3.53) | 649 (34.71) |